Analyst Ratings for Eiger BioPharma (EIGR)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/26/2019 | Citi » Updated 12/3/2021 |
Yigal Nochomovitz | New Coverage | Buy (N/A) |
23.00 (27.00) |
10.61 (1.73) |
-83.69% | Details |
| 1/29/2019 | Baird » Updated 6/30/2023 |
Madhu Kumar | New Coverage | Outperform (N/A) |
5.00 (3.00) |
14.30 (1.73) |
-87.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
